Uflex showcases pharma packaging offerings at CPhI India

Primary packaging plays an important role in the pharma industry, where its purpose ranges beyond providing barrier protection to creating unique brand identity, brand protection and patient communication. At the recently held CPHI India in Greater Noida, Uflex unveiled a portfolio of its latest products in pharma packaging including fast tear strip foil, PET based cold form blister, child resistant & senior friendly foil and branding solutions.
Fast tear strip foil
Conventionally, pharma companies have been using 30-micron and 40-micron soft tempered strip foil pack laminate. Uflex has developed 20-micron pin-hole free soft tempered foil. It contributes in providing higher yield gain of 36% leading to tremendous cost savings. It is produced in-house to impart easy tearability of the laminate without any effort; maintains bursting pressure with reduced foil thickness; and conforms to all regulatory requirements of pharmaceutical products while meeting toxicology requirements.
According to Mr. Amitava Ray, Executive Director, Uflex Ltd., the Fast Tear Strip Foil could have a potential market of 5,000-tonnes annually in India.
PET based cold form blister
In the conventional cold form laminate, there are three layers – nylon, aluminum and PVC. Uflex has developed an ‘Alu-Alu’ packaging where a special polyester film has replaced the conventional nylon and PVC while retaining aluminium, making it an indigenous development. For this, Uflex has also been granted a United States Patent recently.
Child resistant & senior friendly (CRSF) foil
The CRSF foils, developed by Uflex, are available in two types: Push-Through and Peel-Push. As the name suggests, it requires pressure for a child to open, though an adult can open it easily. This protects unintentional damage to the foil, common with conventional blister foils that get easily tampered during handling, affecting the formulation. CRSF foils are also commonly used in regulated markets, and its introduction will be able to bridge a gap existing currently.
Brand identity and protection solutions
Pharma brands face problem of counterfeiting and medication non-adherence in case of chronic therapies. Considering literacy levels and linguistic diversity of India, Uflex is offering tailor-made consumer discernible packaging solutions, which provides unique brand identity and top-of-mind medication adherence communication along with highly specialised brand protection packaging technologies. The non-duplicable, anti-counterfeiting overt and covert technologies, will enable the pharma industry take on the challenge of spurious drugs in the market.
Looking for chemical products? Let suppliers reach out to you!
2026-07-10
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Driving Business, Innovation, and Growth: Saudi PPPP Returns to Riyadh this June
-
Beyond Compliance: Building Quality Maturity
-
Is Less More? The Power of Minimalist Food and Beverage Packaging Designs
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
-
Progesterone Market Potential is Huge
-
PharmaReg AfriSummit
Recommend Reading
-
Glenmark Targets 10–15 Percent CAGR in India by Shifting to High-Margin Drugs AbbVie Deal and New Launches Boost Outlook
-
Wall Street Predicts New Obesity Pills Will Be Priced Near $1000 Like Wegovy and Zepbound Supply and Competition Pressures Mount
-
EFSA Reaffirms Safety of E948 Oxygen and E949 Hydrogen in All Foods No Health Risks Detected
-
EFSA Confirms Safety of Vitamin E TPGS as Food Additive New Opinion Covers Multiple Use Levels
-
Indian Pharma Urges US to Exempt Generics as 50 Percent Tariffs Loom National Security Probe Sparks Supply Fears
-
Melamine Prices Surge Over 10% as Upstream and Downstream Competition Intensifies in China
-
ADNOC Transfers 24.9 Percent OMV Stake to XRG Eyes Borouge Group International Expansion After $16.6 Billion Covestro Deal
-
Chantecaille Enters India: A New Era of Luxury Skincare and Botanical Beauty
-
September Phosphate Market Trends Rise Initially, Then Fall
-
September Ethyl Acetate Price Trends Fluctuate and Consolidate